ReviewPharmacological reports : PR2026
Cancer therapy-related cognitive impairment, part 2: from bench to bedside-and back: why candidate therapies for cancer therapy-related cognitive impairment fail to translate.
Selene Tertemiz et al.PubMed ↗Publisher ↗
No numbers read from the abstract.